Characterisation of voice and swallowing in individuals with chronic cough
- Conditions
- Chronic coughRespiratory - Other respiratory disorders / diseasesMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12622000300774
- Lead Sponsor
- niversity of Canterbury
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
For the chronic cough group:
- 18 years and over
- Able to consent to study
- Frequent coughing lasting longer than eight weeks (Morice et al., 2020)
- Optimal management of chronic cough without resolution, prompting referring
respiratory physician to consider behavioural cough control therapy
For the healthy group:
- 18 years and over
- Able to consent to the study
For the chronic cough group:
- Patient has not received sufficient prior assessment and/or treatment of chronic cough on respiratory physician's review of health information
- Structural abnormalities of the lower airways including emphysema, bronchiectasis, pulmonary fibrosis, or sarcoidosis
- Chronic obstructive pulmonary disease
- Smoking or vaping in the last 6 months
- Upper respiratory tract infection in the last two weeks
- Uncontrolled reflux
- Use of opioids in the last six months
- Use of ACE inhibitors in the last six months
- Current use of neuromodulatory medicines
- Use of spirometry is contraindicated
- Previous or current behavioural treatment for chronic cough by a Speech-Language Therapist or physiotherapist
- Arrived from overseas in the last 14 days
- Displaying symptoms of Covid-19 in the last 14 days
- Been in close physical contact with someone with a suspected or confirmed case of Covid-19 in the last 14 days
- Lack of full vaccination against Covid-19, or unable to prove full vaccination using My Vaccine Pass
- Allergy or intolerance to wheat or gluten
For the healthy group:
- History of frequent coughing lasting longer than eight weeks
Structural abnormalities of the lower airways including emphysema, bronchiectasis, pulmonary fibrosis, or sarcoidosis
- Chronic obstructive pulmonary disease
- Smoking or vaping in the last 6 months
- Upper respiratory tract infection in the last two weeks
- Uncontrolled reflux
- Use of opioids in the last six months
- Use of ACE inhibitors in the last six months
- Current use of neuromodulatory medicines
- Use of spirometry is contraindicated
- Arrived from overseas in the last 14 days
- Displaying symptoms of Covid-19 in the last 14 days
- Been in close physical contact with someone with a suspected or confirmed case of Covid-19 in the last 14 days
- Lack of full vaccination against Covid-19, or unable to prove full vaccination using My Vaccine Pass
- Allergy or intolerance to wheat or gluten
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method